Sign in

CIK 0001847367 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

ALUMIS INC.

Sign in to watch
Ticker
ALMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
650-231-6625
Business address
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
FL2021-001, Inc.
  1. 4/A Open-market buy Director bought 1,562,500 shares at $16.00 ($25,000,000)
  2. 4 Open-market buy 10% owner bought 2,500,000 shares at $16.00 ($40,000,000)
  3. 4 Open-market buy 10% owner bought 2,500,000 shares at $16.00 ($40,000,000)
  4. 4 Open-market buy Director bought 2,500,000 shares at $16.00 ($40,000,000)
  5. 4 Grant or award Director acquired 2,500,000 shares (grant or award)
  6. 4 Grant or award Director acquired 23,529 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 1,703,998 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award General Counsel - Corp Secy acquired 33,796 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Chief Business & Legal Officer acquired 181,818 shares (grant or award)
  14. 4 Grant or award Chief Scientific Officer acquired 216,897 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Chief Development Officer acquired 62,030 shares (grant or award)
  17. 4 Grant or award President, CEO and Chairman acquired 90,804 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 6 · 114 filings